Alkermes plc (ALKS): Next-Year EPS Estimate 255.20%
As of 2026-06-04, Alkermes plc (ALKS) has a next-year EPS growth estimate of 255.20%.
On 2026-05-24, analyst consensus for ALKS's next-year EPS growth shifted from 354.64% to 255.20% — a negative change of 99.44 percentage points. The revised estimate has been sustained across 10 subsequent trading sessions. Current-year growth is projected at -125.79%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 255.20%
- EPS growth this year
- -125.79%
- EPS next quarter (est)
- -$0.01
- Last price
- $43.38
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 255.20% | -125.79% | -$0.01 | $43.38 |
| 2026-06-03 | 255.20% | -125.79% | -$0.01 | $42.76 |
| 2026-06-02 | 255.20% | -125.79% | -$0.01 | $41.32 |
| 2026-06-01 | 255.20% | -125.79% | -$0.01 | $42.27 |
| 2026-05-31 | 255.20% | -125.79% | -$0.01 | $42.19 |
| 2026-05-28 | 255.20% | -125.79% | -$0.01 | $39.94 |
| 2026-05-27 | 255.20% | -125.79% | -$0.01 | $38.09 |
| 2026-05-26 | 255.20% | -125.79% | -$0.01 | $37.35 |
| 2026-05-25 | 255.20% | -125.79% | -$0.01 | $36.80 |
| 2026-05-24 | 255.20% | -125.79% | -$0.01 | $36.80 |
| 2026-05-21 | 354.64% | -117.15% | -$0.01 | $36.95 |
| 2026-05-20 | 356.48% | -117.03% | -$0.01 | $36.98 |
| 2026-05-19 | 356.48% | -117.03% | -$0.01 | $37.00 |
| 2026-05-18 | 356.48% | -117.03% | -$0.01 | $37.19 |
| 2026-05-17 | 356.48% | -117.03% | -$0.01 | $37.48 |
| 2026-05-14 | 356.48% | -117.03% | -$0.01 | $38.36 |
| 2026-05-13 | 356.48% | -117.03% | -$0.01 | $39.17 |
| 2026-05-12 | 356.48% | -117.03% | -$0.01 | $38.29 |
| 2026-05-11 | 356.92% | -117.00% | -$0.01 | $35.47 |
| 2026-05-10 | 356.92% | -117.00% | -$0.01 | $34.99 |
| 2026-05-07 | 353.32% | -118.81% | -$0.01 | $35.40 |
| 2026-05-06 | 353.32% | -118.81% | -$0.01 | $35.32 |
| 2026-05-05 | 261.02% | -130.09% | -$0.03 | $36.25 |
| 2026-05-04 | 244.65% | -133.86% | -$0.54 | $34.17 |
| 2026-05-03 | 244.65% | -133.86% | -$0.54 | $33.38 |
| 2026-04-30 | 244.65% | -133.86% | -$0.54 | $33.71 |
| 2026-04-29 | 245.80% | -133.74% | -$0.54 | $33.71 |
| 2026-04-28 | 245.80% | -133.74% | -$0.54 | $34.14 |
| 2026-04-27 | 245.80% | -133.74% | -$0.54 | $33.73 |
| 2026-04-26 | 245.80% | -133.74% | -$0.54 | $33.31 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Alkermes plc's next-year EPS growth estimate?▾
As of 2026-06-04, Alkermes plc (ALKS) has a next-year EPS growth estimate of 255.20%, based on analyst consensus.
When was the latest EPS estimate revision for ALKS?▾
The most recent revision occurred on 2026-05-24, when analysts adjusted the next-year EPS growth estimate from 354.64% to 255.20%.
What sector and industry does Alkermes plc belong to?▾
Alkermes plc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ALKS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Alkermes plc (ALKS) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports